Barbara A. Fox

Affiliated with

Research Area

Biography

Barbara A. Fox has not added Biography.
If you are Barbara A. Fox and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 19	2013

Other Publications

Article	Year
De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature\| PubMed ID: 11859373	2002
Plasmodium falciparum: fine-mapping of an epitope of the serine repeat antigen that is a target of parasite-inhibitory antibodies. Experimental parasitology\| PubMed ID: 12243740	2002
Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitology international\| PubMed ID: 12421632	2002
Organisation and sequence determination of glutamine-dependent carbamoyl phosphate synthetase II in Toxoplasma gondii. International journal for parasitology\| PubMed ID: 12547350	2003
Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. International journal for parasitology\| PubMed ID: 15003493	2004
Toxoplasma gondii: generation of novel truncation mutations in the linker domain of dihydrofolate reductase-thymidylate synthase. Experimental parasitology\| PubMed ID: 15172226	2004
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16751369	2006
TLR adaptor MyD88 is essential for pathogen control during oral toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18714019	2008
Genetic identification of essential indels and domains in carbamoyl phosphate synthetase II of Toxoplasma gondii. International journal for parasitology\| PubMed ID: 18992249	2009
Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19124750	2009
Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryotic cell\| PubMed ID: 19218423	2009
Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infection and immunity\| PubMed ID: 19528214	2009
Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vac... Infection and immunity\| PubMed ID: 19797073	2009
CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infection and immunity\| PubMed ID: 20498261	2010
Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii. Infection and immunity\| PubMed ID: 20605980	2010
Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell host & microbe\| PubMed ID: 21147463	2010
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryotic cell\| PubMed ID: 21531875	2011
Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS pathogens\| PubMed ID: 21931552	2011
An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii. Infection and immunity\| PubMed ID: 22104110	2012
Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii. Molecular and biochemical parasitology\| PubMed ID: 22580100	2012
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23225891	2013
Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment. Cancer research\| PubMed ID: 23704211	2013